Impaired Dual-Specificity Protein Phosphatase DUSP4 Reduces Corticosteroid Sensitivity

Area of Science:

• Biochemistry
• Molecular Biology
• Immunology

Background:

• Glucocorticoid receptor (GR) phosphorylation at Ser226 impairs nuclear translocation, leading to corticosteroid insensitivity in severe asthma.
• Protein phosphatase 2A regulates c-Jun N-terminal kinase (JNK) 1 and GR-Ser226 signaling in this mechanism.

Purpose of the Study:

• To investigate the role of dual-specificity phosphatases (DUSPs) in regulating corticosteroid sensitivity.
• To identify DUSP4 as a key phosphatase involved in JNK dephosphorylation and GR signaling.

Main Methods:

• Small interfering RNA (siRNA) was used to knock down DUSPs (DUSP1, 4, 8, 16, 22) in U937 cells.
• Corticosteroid sensitivity was assessed by measuring dexamethasone effects on FKBP51, TNFα-induced cytokine expression, and GR translocation.
• Western blotting, imaging flow cytometry, and fluorescence-based assays were employed to analyze protein levels, phosphorylation, complex formation, and phosphatase activity.

Main Results:

• DUSP4 knockdown increased GR-Ser226 and JNK1 phosphorylation, reduced GR nuclear translocation, and impaired corticosteroid sensitivity.
• DUSP4 was found to associate with both GR and JNK1.
• Reduced DUSP4 expression in severe asthmatics correlated negatively with GR-Ser226 and JNK1 phosphorylation.
• Formoterol treatment enhanced DUSP4 activity and restored corticosteroid sensitivity in DUSP4-knockdown cells.

Conclusions:

• DUSP4 dephosphorylates JNK1 and GR-Ser226, thereby regulating corticosteroid sensitivity.
• DUSP4 activation by formoterol can restore corticosteroid sensitivity in severe asthma.
• DUSP4 represents a potential novel therapeutic target for severe asthma management.